NewLake Capital Partners, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NewLake Capital Partners, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.07M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $50.13M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $47.30M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $45.00M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $28.06M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $11.66M | Mar 18, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.32M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $26.12M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $24.59M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $21.98M | Mar 11, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.25M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $26.79M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $24.66M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $22.52M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $11.50M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($10.59M) | Mar 18, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.46M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $43.35M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $40.08M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $37.01M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $26.70M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $7.35M | Mar 18, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $420.83M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $431.54M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $433.29M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $454.25M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $460.88M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $144.18M | Mar 18, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.14M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $27.56M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $21.34M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $23.31M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $21.55M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $3.15M | Mar 18, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $387.94M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $396.77M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $404.59M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $423.55M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $427.56M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $134.76M | Mar 18, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($59.45M) | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | ($50.07M) | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | ($40.91M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | ($32.49M) | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | ($23.57M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($17.15M) | Mar 18, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.94M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $20.21M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $25.84M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $45.19M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $127.10M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $19.62M | Mar 18, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Mar 18, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | (1) | Mar 18, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.55M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 20.51M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | 20.50M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 21.41M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | 21.24M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | 7.76M | Mar 18, 2022 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.33M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $34.25M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $33.06M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $28.99M | Mar 11, 2024 |
| FY2022 | Dec 31, 2021 | $11.67M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $5.16M | Mar 18, 2022 |